Cited by 248Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

Drzezga, A., Grimmer, T., Henriksen, G., Mühlau, M., Perneczky, R., Miederer, I., Praus, C., Sorg, C., Wohlschläger, A., Riemenschneider, M., Wester, H. J., Foerstl, H., Schwaiger, M., Kurz, A.·2009·Neurology

DOI 10.1212/wnl.0b013e3181a2e8d0

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To examine the influence of the APOE genotype on levels of beta-amyloid (Abeta) plaque load and atrophy in patients with Alzheimer disease (AD) in vivo. METHODS: Thirty-two patients with moderate AD were divided into carriers and noncarriers of the epsilon4 allele. These groups were matched for age, disease duration, education, and cognitive impairment. In all subjects, [11C]PIB-PET was performed for measurement of cerebral Abeta plaque deposition and cranial MRI for the assessment of gray matter volume by voxel-based morphometry (VBM) and for correction of partial volume effects (PVE) in the PET data. Voxel-based comparisons (SPM5) were performed between patient groups and healthy control populations and completed with multiple regression analyses between imaging data and epsilon4 allele frequency. RESULTS: Compared to controls, AD-typical patterns of [11C]PIB retention and atrophy were detected in both epsilon4-positive and epsilon4-negative patient groups. In direct comparison, significantly stronger and more extended [11C]PIB uptake was found in epsilon4-positive patients in bilateral temporoparietal and frontal cortex, surviving PVE correction. VBM analysis demonstrated comparable levels of atrophy in both patient groups. Regression analyses revealed a linear association between higher epsilon4 allele frequency and stronger temporoparietal Abeta plaque deposition, independently of other confounds. No major correlation between epsilon4 allele frequency and gray matter decrease was observed. CONCLUSION: These results indicate that the epsilon4-positive APOE genotype not only represents a risk factor for Alzheimer disease (AD), but also results in higher levels of Abeta plaque deposition in epsilon4-positive patients with AD compared to age-matched epsilon4-negative patients with similar levels of cognitive impairment and brain atrophy. The potential role of Abeta plaque imaging for patient inclusion and follow-up in anti-amyloid therapy trials is strengthened by these findings.

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3181a2e8d0

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Thresholding of statistical maps in functional neuroimaging using the false discovery rate
Genovese, C. R., Lazar, N. A., & Nichols, T. (2002) · NeuroImage · doi:10.1006/nimg.2001.1037 · Cited by 4,923
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958
In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease
Baron, J., Chételat, G., Desgranges, B., Perchey, G., Landeau, B., Sayette, V. D. L., & Eustache, F. (2001) · NeuroImage · doi:10.1006/nimg.2001.0848 · Cited by 699
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein
Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinistö, L., Halonen, P., & Kontula, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331902 · Cited by 493
PET imaging of amyloid in Alzheimer's disease
Nordberg, A. K. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00853-1 · Cited by 462
Decreases in regional cerebral blood flow with normal aging
Martin, A. J., Friston, K. J., Colebatch, J. G., & Frackowiak, R. S. J. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.121 · Cited by 393

Show all 38 references

Research works printed but not linked: 1

Grundman M Black R. Clinical trials of bapineuzumab a beta-amyloid-targeted immunotherapy in patients with mild-to-moderate Alzheimer’s disease. In: International Conference on Alzheimer’s Disease (ICAD)

Sorted by citations

Items 101–200 of 248

The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort
Li, C., Initiative, A. D. N., Loewenstein, D., Duara, R., Cabrerizo, M., Barker, W., & Adjouadi, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170286 · Cited by 42
The Interaction of APOE Genotype by Age in Amnestic Mild Cognitive Impairment: A Voxel-Based Morphometric Study
Chen, J., Shu, H., Wang, Z., Liu, D., Shi, Y., Zhang, X., & Zhang, Z. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141677 · Cited by 41
A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
Li, L., Yu, X., Sheng, C., Jiang, X., Zhang, Q., Han, Y., & Jiang, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00315-z · Cited by 40
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: A cross-validation study using voxel-based multi-modal partial least squares
Chen, K., Ayutyanont, N., Langbaum, J. B. S., Fleisher, A., Reschke, C., Lee, W., Liu, X., Alexander, G. E., Bandy, D., Caselli, R. J., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.005 · Cited by 39
Neuroinflammatory Cytokines - The Common Thread in Alzheimer Pathogenesis
Griffin, W. S. T., Barger, S. W., & Chairman, D. P. A. V. (2011) · European Neurological Review · doi:10.17925/enr.2011.06.02.89 · Cited by 39
Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease
Wang, X., Wang, J., He, Y., Li, H., Yuan, H., Evans, A. C., Yu, X., Yong He, A., & Wang, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142556 · Cited by 38
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease
Kennedy, R., Cutter, G., & Schneider, L. S. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.03.003 · Cited by 42
Amyloid-plaque imaging in early and differential diagnosis of dementia
Drzezga, A. E. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-009-0330-9 · Cited by 37
Self-citation
APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer′s disease
Zhang, W., Hu, C., Yang, Z., Zhou, Q., Peng, D., Yuan, X., Lv, Z., Pang, S., Jiang, W., Yang, C., et al. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.130117 · Cited by 36
Cerebrospinal Fluid Markers for Alzheimer's Disease over the Lifespan: Effects of Age and the APOEε4 Genotype
Popp, J., Lewczuk, P., Frommann, I., Kölsch, H., Kornhuber, J., Maier, W., & Jessen, F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100561 · Cited by 36
A non-invasive, rapid method to genotype late-onset Alzheimer′s disease-related apolipoprotein E gene polymorphisms
Yi, L., Wu, T., Luo, W., Zhou, W., & Wu, J. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.125332 · Cited by 35
Cholesterol and LDL Relate to Neuritic Plaques and to APOE4 Presence but Not to Neurofibrillary Tangles
Lesser, G. T., Beeri, M. S., Schmeidler, J., Purohit, D. P., & Haroutunian, V. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563755 · Cited by 37
The role of positron emission tomography imaging in understanding Alzheimer’s disease
Barthel, H., Seibyl, J. P., & Sabri, O. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1023296 · Cited by 34
APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points
Toledo, J. B., Habes, M., Sotiras, A., Bjerke, M., Yong Fan, A., Weiner, M. W., Shaw, L. M. J., Davatzikos, C. A., Trojanowski, J. Q., & Initiative, A. D. N. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181282 · Cited by 36
Relationship of Amyloid-Beta Burden With Age-At-Onset in Alzheimer Disease
Choo, I. H., Lee, D. Y., Kim, J. W., Seo, E. H., Lee, D. S., Kim, Y. K., Kim, S. G., Park, S. Y., Woo, J. I., & Yoon, E. J. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318202bf3a · Cited by 35
Quantitative neuropathological assessment to investigate cerebral multi-morbidity
Attems, J., Neltner, J. H., & Nelson, P. T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0085-y · Cited by 32
APOE ε4 influences β‐amyloid deposition in primary progressive aphasia and speech apraxia
Josephs, K. A., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Lowe, V. J., Jack, C. R., & Whitwell, J. L. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.004 · Cited by 33
Correlation Between Urine Formaldehyde and Cognitive Abilities in the Clinical Spectrum of Alzheimer’s Disease
Wang, Y., Pan, F., Xie, F., He, R., & Guo, Q. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.820385 · Cited by 33
Disrupted topology of the resting state structural connectome in middle-aged APOE ε4 carriers
Korthauer, L. E., Zhan, L., Ajilore, O., Leow, A., & Driscoll, I. F. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.05.052 · Cited by 31
Impact of apolipoprotein ɛ4–cerebrospinal fluid beta‐amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment
Chiang, G. C.-Y., Insel, P. S., Tosun, D., Schuff, N. W., Truran‐Sacrey, D., Raptentsetsang, S. T., Thompson, P. M., Reiman, E. M., Jack, C. R., Fox, N. C., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.010 · Cited by 31
Effects of DDT on Amyloid Precursor Protein Levels and Amyloid Beta Pathology: Mechanistic Links to Alzheimer’s Disease Risk
Eid, A., Mhatre‐Winters, I., Sammoura, F. M., Edler, M. K., von Stein, R., Hossain, M. M., Han, Y., Lisci, M., Carney, K., Konsolaki, M., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10576 · Cited by 31
Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid
Alexopoulos, P., Tsolakidou, A. F., Roselli, F., Arnold, A., Grimmer, T., Westerteicher, C., Leante, M. R., Förstl, H., Livrea, P., Kurz, A., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.009 · Cited by 31
Self-citation
Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment
Stowe, A. M., Ireland, S. J., Ortega, S. B., Chen, D., Huebinger, R. M., Tarumi, T., Harris, T. S., Cullum, C. M., Rosenberg, R. N., Monson, N. L., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0910-x · Cited by 27
ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOEε4-associated Alzheimer’s disease
Chang, Y., Hsu, S., Huang, S., Huang, C., Chang, W., Lien, C.-Y., Lee, J., Lee, C., & Chang, C. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0563-3 · Cited by 29
Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease
Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Graff‐Radford, J., Ertekin‐Taner, N., Machulda, M. M., Duffy, J. R., Schwarz, C. G., Senjem, M. L., Jack, C. R., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.08.012 · Cited by 29
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel‐based analysis for entorhinal cortex atrophy
Tateno, A., Sakayori, T., Kawashima, Y., Higuchi, M., Suhara, T., Mizumura, S., Mintun, M. A., Skovronsky, D., Honjo, K., Ishihara, K., et al. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4173 · Cited by 28
Voxel-based morphometry in Alzheimers disease and mild cognitive impairment: Systematic review of studies addressing the frontal lobe
Ribeiro, L. G., & Busatto, G. F. (2016) · Dementia & Neuropsychologia · doi:10.1590/s1980-5764-2016dn1002006 · Cited by 28
Factors Influencing Alzheimer’s Disease Risk: Whether and How They are Related to the APOE Genotype
Zhang, R., Xu, X., Yu, H., Xu, X., Wang, M., & Le, W. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-021-00814-5 · Cited by 31
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
Chincarini, A., Peira, E., Morbelli, S. D., Pardini, M., Bauckneht, M., Arbizu, J., Castelo-Branco, M. S., Büsing, K. A., de Mendonça, A., Didic, M., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101846 · Cited by 27
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance
Saeed, U., Desmarais, P., & Masellis, M. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1956904 · Cited by 27
Self-Association and Stability of the ApoE Isoforms at Low pH: Implications for ApoE–Lipid Interactions
Garai, K., Baban, B. A., & Frieden, C. (2011) · Biochemistry · doi:10.1021/bi2006702 · Cited by 27
Effects of APOE ɛ4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment
Kim, H. J., Ye, B. S., Yoon, C. W., Cho, H., Noh, Y., Kim, G. H., Choi, Y. S., Kim, J., Jeon, S., Lee, J. M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.009 · Cited by 29
Perspectives for Multimodal Neurochemical and Imaging Biomarkers in Alzheimer's Disease
Teipel, S. J., Sabri, O., Grothe, M. J., Barthel, H., Prvulovic, D., Büerger, K., Bokde, A. L. W., Ewers, M., Hoffmann, W. U., & Hampel, H. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129030 · Cited by 27
Revista Española de Geriatría y Gerontología
Santos, R. P., Torres, C. F., Martín‐Arranz, M. D., de Parga, J. M. S., & Martínez, M. A. (2016) · Cited by 26
Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
Lin, S.-Y., Lin, K., Lin, P.-C., Huang, C.-C., Chang, C., Lee, Y., Hsiao, I., Yen, T., Huang, W.-S., Yang, B., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0566-0 · Cited by 26
Knowing Me, Knowing You: Can a Knowledge of Risk Factors for Alzheimer's Disease Prove Useful in Understanding the Pathogenesis of Parkinson's Disease?
Sutherland, G. T., Siebert, G. A., Kril, J. J., & Mellick, G. D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110026 · Cited by 26
Differential Effects of APOE Genotypes on the Anterior and Posterior Subnetworks of Default Mode Network in Amnestic Mild Cognitive Impairment
Yuan, B., Xie, C., Shu, H., Liao, W., Wang, Z., Liu, D., & Zhang, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160353 · Cited by 25
Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase
Woody, S. K., Zhou, H., Ibrahimi, S., Dong, Y., & Zhao, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160307 · Cited by 23
Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network
Initiative, T. A. D. N., Jin, Y., Su, Y., Zhou, X., & Huang, S. (2016) · EURASIP Journal on Bioinformatics and Systems Biology · doi:10.1186/s13637-016-0046-9 · Cited by 25
Fueling the brain - the role of apolipoprotein E in brain energy metabolism and its implications for Alzheimer's disease
Budny, V., Ruminot, I., Wybitul, M., Treyer, V., Barros, L. F., & Tackenberg, C. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03550-w · Cited by 25
Structural differences between apolipoprotein E3 and E4 as measured by 19F NMR
Garai, K., Mustafi, S. M., Baban, B. A., & Frieden, C. (2009) · Protein Science · doi:10.1002/pro.283 · Cited by 23
Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints
Teipel, S. J., Cavedo, E., Weschke, S., Grothe, M. J., Rojkova, K., Fontaine, G., Dauphinot, L., Gonzalez-Escamilla, G., Potier, M.-C., Bertin, H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.016 · Cited by 22
iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta
Ding, Y., Palecek, S. P., & Shusta, E. V. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00580-2 · Cited by 22
LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo
Grimmer, T., Goldhardt, O., Guo, L., Yousefi, B. H., Förster, S., Drzezga, A. E., Sorg, C., Alexopoulos, P., Förstl, H., Kurz, A., et al. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.01.016 · Cited by 23
Self-citation
Genetic Associations of Autopsy-Confirmed Vascular Dementia Subtypes
Jones, E. L., Kalaria, R. N., Sharp, S. I., O'Brien, J. T., Francis, P. T., & Ballard, C. G. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000327171 · Cited by 22
Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors
Sui, X., & Rajapakse, J. C. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.10.026 · Cited by 21
Interleukin-1A −889C/T polymorphism and risk of Alzheimer’s disease: a meta-analysis based on 32 case–control studies
Qin, X. Y., Peng, Q., Zeng, Z., Chen, Z., Lin, L., Deng, Y., Huang, X., Xu, J., Wu, H., Huang, S., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6381-6 · Cited by 20
A flow cytometry–based in vitro assay reveals that formation of apolipoprotein E (ApoE)–amyloid beta complexes depends on ApoE isoform and cell type
Kara, E., Marks, J. D., Roe, A. D., Commins, C., Fan, Z., Calvo-Rodriguez, M., Wegmann, S., Hudry, E., & Hyman, B. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001388 · Cited by 20
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease
Mattsson, N., Eriksson, O., Lindberg, O. E., Schöll, M., Lampinen, B., Nilsson, M., Insel, P. S., Lautner, R., Strandberg, O. T., van Westen, D., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.003 · Cited by 20
The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer’s disease patients
Mills, J. D., Sheahan, P. J., Lai, D., Kril, J. J., Janitz, M., & Sutherland, G. T. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3516-8 · Cited by 17
Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people
Shen, S., Zhou, W., Chen, X., & Zhang, J. (2019) · European Journal of Neurology · doi:10.1111/ene.13987 · Cited by 18
Brain Homotopic Connectivity in Mild Cognitive Impairment APOE-ε4 Carriers
Shi, J.-Y., Wang, P., Wang, B.-H., Xu, Y. J., Chen, X., & Li, H. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.011 · Cited by 18
Association of APOE ε4 with cerebral gray matter volumes in non-demented older adults: The MEMENTO cohort study
Régy, M., Dugravot, A., Sabia, S., Fayossé, A., Mangin, J., Marie Chupin, A., Fischer, C., Bouteloup, V., Dufouil, C., Chêne, G., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.118966 · Cited by 23
Apolipoprotein E4 Affects Topographical Changes in Hippocampal and Cortical Atrophy in Alzheimer's Disease Dementia: A Five-Year Longitudinal Study
Kim, Y. J., Cho, H., Kim, Y. J., Ki, C., Chung, S. J., Ye, B. S., Kim, H. J., Kim, J., Kim, S. T., Lee, K. H., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141773 · Cited by 18
The Recent Updates of Therapeutic Approaches Against Aβ for the Treatment of Alzheimer's Disease
Ling, S., Zhou, J., Rudd, J. A., Hu, Z., & Fang, M. (2011) · The Anatomical Record · doi:10.1002/ar.21425 · Cited by 17
Clusterin (APOJ) in Alzheimer’s Disease: An Old Molecule with a New Role
Woody, S. K., & Zhao, L. (2016) · InTech eBooks · doi:10.5772/64233 · Cited by 17
Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer’s disease.
Ortner, M., Kurz, A., Alexopoulos, P., Auer, F., Diehl-Schmid, J., Drzezga, A., Förster, S., Förstl, H., Perneczky, R., Sorg, C., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.019 · Cited by 17
Self-citation
Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene
Traversy, M.-T., Vandal, M., Tremblay, C., Tournissac, M., Giguère-Rancourt, A., Bennett, A. D., & Calon, F. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.028 · Cited by 16
Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease
Jung, J. H., Jeon, S., Baik, K., Lee, Y. H., Chung, S. J., Yoo, H. S., Jeong, S. H., Sohn, Y. H., Lee, P. H., & Ye, B. S. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.004 · Cited by 16
Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer’s Disease
Taylor, M., Sullivan, D. K., Keller, J. E., Burns, J. M., & Swerdlow, R. H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.899612 · Cited by 17
Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis
Wang, X.-B., Cui, N.-H., Yang, J., Qiu, X.-P., Gao, J.-J., Yang, N., & Zheng, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111406 · Cited by 15
Angiotensin‐converting enzyme insertion/deletion polymorphism and the longitudinal progression of Alzheimer's disease
Chou, P., Wu, M., Chou, M., Chien, I., & Yang, Y. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12929 · Cited by 15
Postmenopausal cognitive changes and androgen levels in the context of apolipoprotein E polymorphism
Bojar, I., Pinkas, J., Gujski, M., Owoc, A., Raczkiewicz, D., & Rothenberg, K. G. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.62869 · Cited by 16
Polymorphisms of apolipoprotein E gene and cognitive functions of postmenopausal women, measured by battery of computer tests - Central Nervous System Vital Signs.
Bojar, I., Wójcik‐Fatla, A., Owoc, A., & Lewiñski, A. (2012) · PubMed · Cited by 14
Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging
Initiative, A. D. N., Chiotis, K., Carter, S. F., Farid, K., Savitcheva, I., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3115-5 · Cited by 16
Insights into cognitive aging and Alzheimer’s disease using amyloid PET and structural MRI scans
Duara, R., Barker, W., Loewenstein, D., Greig, M. T., Rodriguez, R. A., Goryawala, M., Zhou, Q., & Adjouadi, M. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0110-6 · Cited by 15
Cognitive functions, apolipoprotein E genotype and hormonal replacement therapy of postmenopausal women.
Bojar, I., Gujski, M., Raczkiewicz, D., & Rothenberg, K. G. (2013) · PubMed · Cited by 13
Effect of APOE ε4 genotype on amyloid‐β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment
Li, W., Li, R., Yan, S., Zhao, Z., Shan, Y., Qi, Z., Lu, J., & Initiative, A. D. N. (2022) · European Journal of Neurology · doi:10.1111/ene.15656 · Cited by 10
Amyloid-Related Imaging Abnormalities in AβPP Duplication Carriers
Chamard-Witkowski, L., Wallon, D., Pijoff, A., Berger, É., Viennet, G., Hannequin, D., & Magnin, É. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130629 · Cited by 12
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
Korthauer, L. E., Giugliano, R. P., Guo, J., Sabatine, M. S., Sever, P., Keech, A., Atar, D., Kurtz, C., Ruff, C. T., Mach, F., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0266615 · Cited by 11
APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
Brugulat‐Serrat, A., Sánchez‐Benavides, G., Cacciaglia, R., Salvadó, G., Shekari, M., Collij, L. E., Buckley, C. J., van Berckel, B. N. M., Perissinotti, A., Niñerola‐Baizán, A., et al. (2023) · EJNMMI Research · doi:10.1186/s13550-023-00967-6 · Cited by 10
Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
Wei, H., Li, B., Ng, K. P., Fu, Q., Dong, S., Ba, M., & Kong, M. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001496 · Cited by 11
Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
Grimmer, T., Alexopoulos, P., Tsolakidou, A. F., Guo, L., Henriksen, G., Yousefi, B. H., Förstl, H., Sorg, C., Kurz, A., Drzezga, A. E., et al. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/712048 · Cited by 10
Self-citation
Cognitive Function, APOE Gene Polymorphisms, and Thyroid Status Associations in Postmenopausal Women in Poland
Bojar, I., Stasiak, M., Cyniak-Magierska, A., Raczkiewicz, D., & Lewiñski, A. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000449373 · Cited by 10
The Brain Network Hub Degeneration in Alzheimer’s Disease
Jin, S., Wang, J., & Yong He, A. (2024) · Biophysics Reports · doi:10.52601/bpr.2024.230025 · Cited by 11
Pathomechanisms of Atrophy in Insular Cortex in Alzheimer’s Disease
Moon, Y., Moon, W., & Han, S. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514566113 · Cited by 9
Relationship between Urinary Alzheimer-Associated Neuronal Thread Protein and Apolipoprotein Epsilon 4 Allele in the Cognitively Normal Population
Li, Y., Kang, M., Sheng, C., Chen, G., Li, T., Wang, J., Cai, Y., Wang, R., & Han, Y. (2020) · Neural Plasticity · doi:10.1155/2020/9742138 · Cited by 9
Developing and validating a prediction tool for cerebral amyloid angiopathy neuropathological severity
Chu, C., Wang, Y., Ma, L., Mutimer, C. A., Ji, G., Shi, H., Yassi, N., Masters, C. L., Goudey, B., Jin, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14583 · Cited by 8
Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
Argilés, J. A. M., Gasparini-Berenguer, R., Gutiérrez-Agulló, M., Muñoz-Ruiz, C., Sánchez-Payá, J., & Leiva-Santana, C. (2016) · BioMed Research International · doi:10.1155/2016/1390620 · Cited by 9
Pattern analysis of the interaction of regional amyloid load, cortical thickness and APOE genotype in the progression of Alzheimer's disease
Li, C., Fang, C., Cabrerizo, M., Barreto, A. B., Andrian, J. H., Duara, R., Loewenstein, D., & Adjouadi, M. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217994 · Cited by 8
A Neuroimaging Feature Extraction Model for Imaging Genetics with Application to Alzheimer's Disease
Li, C., Fang, C., Adjouadi, M., Cabrerizo, M., Barreto, A. B., Andrian, J. H., Duara, R., & Loewenstein, D. (2017) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2017.00-85 · Cited by 8
Apolipoprotein E ε4 accelerates the longitudinal cerebral atrophy in open access series of imaging studies-3 elders without dementia at enrollment
Huang, Y., Shan, Y., Qin, W., & Zhao, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1158579 · Cited by 9
Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study
Suwa, A., Nishida, K., Utsunomiya, K., Nonen, S., Yoshimura, M., Takekita, Y., Wakeno, M., Tajika, A., Yoshino, M., Koshikawa, Y., et al. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000440714 · Cited by 7
Effects of APOE ε2 allele on basal forebrain functional connectivity in mild cognitive impairment
Liu, X., Zeng, Q., Luo, X., Li, K., Xu, X., Hong, L., Li, J., Guan, X., Xu, X., Huang, P., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14038 · Cited by 7
More than microglia: myeloid cells and biomarkers in neurodegeneration
Kodosaki, E., Bell, R., Sogorb‐Esteve, A., Wiltshire, K., Zetterberg, H., & Heslegrave, A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1499458 · Cited by 6
Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer’s Disease, Independent of Amyloid Load and APOE Genotype
Li, C., Initiative, A. F. T. A. D. N., Duara, R., Loewenstein, D., Izquierdo, W., Cabrerizo, M., Barker, W., & Adjouadi, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180231 · Cited by 6
Amyloiddarstellung mittels Positronenemissionstomographie
Grimmer, T., Drzezga, A. E., & Kurz, A. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-2951-6 · Cited by 6
Self-citation
Review of Quantitative Methods for the Detection of Alzheimer’s Disease with Positron Emission Tomography
Perron, J., & Ko, J. H. (2022) · Applied Sciences · doi:10.3390/app122211463 · Cited by 5
Effects of an APOE Promoter Polymorphism on Fronto-Parietal Functional Connectivity During Nondemented Aging
Zhang, Q., Wu, L., Du, C., Xu, K., Sun, J., Zhang, J., Li, H., & Li, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00183 · Cited by 5
Longitudinal Changes in 18F-Flutemetamol Amyloid Load in Cognitively Intact APOE4 Carriers Versus Noncarriers: Methodological Considerations
Luckett, E. S., Schaeverbeke, J. M., Meyer, S. D., Adamczuk, K., Laere, K. V., Dupont, P. J., & Vandenberghe, R. R. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103321 · Cited by 5
Predicting severity of cerebral amyloid angiopathy neuropathology: A modeling approach using NACC and ROSMAP data
Chu, C., Ma, L., Wang, Y., Huynh, A. L. H., Dunstan, M. K., Cui, X., Masters, C. L., Goudey, B., Jin, L., & Pan, Y. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70057 · Cited by 4
Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer’s Disease
Nagaraja, N., Wang, W., Duara, R., DeKosky, S. T., & Vaillancourt, D. E. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220624 · Cited by 4
Perfiles genéticos de longevidad y envejecimiento saludable en nonagenarios del País Vasco
Martín, X. E., Busto, F. G., Artabe, I. A., Niso, J. B., Boyer, J. G., de Vicuña, V. O. D. M. G., & de Pancorbo, M. M. (2011) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2011.04.005 · Cited by 5
Biomarkers of Alzheimer’s Disease
Saeed, U., Swardfager, W., Black, S. E., & Masellis, M. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-2414-6_8 · Cited by 4
In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease
Cui, J., Zufferey, V., & Kherif, F. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000225 · Cited by 4
Discovering Aberrant Patterns of Human Connectome in Alzheimer's Disease via Subgraph Mining
Shao, J., Yang, Q., Wohlschlaeger, A. M., & Sorg, C. (2012) · IEEE ... International Conference on Data Mining workshops · doi:10.1109/icdmw.2012.9 · Cited by 4
Self-citation
The APOE gene and cognitive function in non-demented and Alzheimer's disease patients
Payton, A. (2009) · Reviews in Clinical Gerontology · doi:10.1017/s0959259809990268 · Cited by 3
Intraneuronal binding of amyloid beta with reelin—Implications for the onset of Alzheimer’s disease
Kobro‐Flatmoen, A., & Omholt, S. W. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012709 · Cited by 2
[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study
Quattrini, G., Gatti, E., Peretti, D. E., Aiello, M., Chevalier, C., Lathuilière, A., Park, R., Pievani, M., Salvatore, M., Scheffler, M., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07299-8 · Cited by 4
Divergent Network Patterns of Amyloid-β Deposition in Logopenic and Amnestic Alzheimer’s Disease Presentations
Leyton, C. E., Cassidy, B., Villemagne, V. L., Jones, G. R., Kwok, J. B., Rowe, C. C., Ballard, K. J., Piguet, O., & Hodges, J. R. (2015) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.09.004 · Cited by 3

Authors: Drzezga, A., Grimmer, T., Henriksen, G., Mühlau, M., Perneczky, R., Miederer, I., Praus, C., Sorg, C., Wohlschläger, A., Riemenschneider, M., Wester, H. J., Foerstl, H., Schwaiger, M., & Kurz, A.
Affiliations: Technical University of Munich (DE)
From the Departments of Nuclear Medicine (A.D., G.H., I.M., C.P., A.W., H.J.W., M.S.), Psychiatry and Psychotherapy (T.G., R.P., C.S., M.R., H.F., A.K.), Neurology (M.M.), and Neuroradiology (A.W.), Technische Universität München, Munich, Germany.
ORCID: Drzezga, A.
Grimmer, T.
Perneczky, R.
Miederer, I.
Sorg, C.
Riemenschneider, M.
Schwaiger, M.
Kurz, A.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-04-28
Volume: 72
Issue: 17
Pages: 1487-1494
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0b013e3181a2e8d0
OpenAlex: W2050255138
Cited by: 248
References: 38
Citations by year: 2026: 1 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 16 · 2021: 6 · 2020: 8 · 2019: 9 · 2018: 17 · 2017: 13 · 2016: 16 · 2015: 18 · 2014: 22 · 2013: 15 · 2012: 25
FWCI: 18.70
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
mediaTUM (Technical University of Munich) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: APOE ε4, Alzheimer's disease, amyloid plaques, gray matter atrophy, 11C-PiB PET, amyloid imaging, genetic risk factors, temporoparietal cortex, partial volume correction
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Aniline Compounds, Apolipoproteins E, Brain, Carbon Radioisotopes, DNA Mutational Analysis, Female, Gene Frequency, Genetic Testing, Genotype, Humans, Male, Middle Aged, Polymorphism, Genetic, Risk Factors, Thiazoles, Amyloid beta-Peptides, Genetic Predisposition to Disease, Positron-Emission Tomography, Benzothiazoles, Apolipoprotein E4, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks